However, these properties of FXR indicate the potent contribution to the protection against fatty and even non-fatty livers from surgical stress and/or injury and to improve steatosis via p62/SQSTM1 and SHP in various clinical settings (Fig. 6). The gene discussed is SQSTM1; the disease is steatosis.